UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Current pharmaceutical design, ISSN 1381-6128, 05/2006, Volume 12, Issue 14, p. 1751
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 05/2014, Volume 57, Issue 10, pp. 3891 - 3911
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Endocannabinoids - metabolism | Analgesics - pharmacology | Receptor, Cannabinoid, CB2 - physiology | Endocannabinoids - pharmacology | Monoacylglycerol Lipases - antagonists & inhibitors | Humans | Monoacylglycerol Lipases - physiology | Receptor, Cannabinoid, CB2 - drug effects | Awards and Prizes | Amidohydrolases - antagonists & inhibitors | Chemistry, Pharmaceutical | Receptor, Cannabinoid, CB1 - physiology | Cannabinoids - pharmacology | Animals | Amidohydrolases - physiology | Receptor, Cannabinoid, CB1 - drug effects | Index Medicus
Journal Article
Journal
Expert opinion on emerging drugs, ISSN 1472-8214, 03/2009, Volume 14, Issue 1, pp. 43 - 65
clinical trial | G protein-coupled receptor | endocannabinoid | immunomodulation | ligands | pain | rimonabant | translational biomedicine | drugs | taranabant | addiction | AM4113 | 2-arachidonoylglycerol | metabolic syndrome | inflammation | neutral antagonist | substance abuse | anandamide | diabetes | insulin resistance | overweight | steatosis | obesity | Drugs | Obesity | Immunomodulation | Neutral antagonist | Inflammation | Substance abuse | Metabolic syndrome | Translational biomedicine | Anandamide | Overweight | Steatosis | Pain | Addiction | Endocannabinoid | Rimonabant | Taranabant | Clinical trial | Insulin resistance | Ligands | Diabetes | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cannabinoid Receptor Modulators - metabolism | Animals | Obesity - drug therapy | Signal Transduction - drug effects | Humans | Drug Design | Obesity - physiopathology | Clinical Trials as Topic | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Drug Evaluation, Preclinical | Drug Delivery Systems | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 2935 - 11
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Drug abuse | Multiple sclerosis | Nuclear magnetic resonance--NMR | Protein purification | Mass spectroscopy | Neuropathy | Drug development | Crystallography | X-ray crystallography | Trypsin | Cannabinoids | Plasmids | Ligands | Protein structure | Binding sites | Metabolic disorders
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 08/2010, Volume 120, Issue 8, pp. 2953 - 2966
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Pyrazoles - therapeutic use | Obesity - drug therapy | Obesity - complications | Liver - metabolism | Mice, Inbred C57BL | Insulin Resistance | Morpholines - pharmacology | Male | Receptor, Cannabinoid, CB1 - physiology | Obesity - metabolism | Triglycerides - metabolism | Leptin - physiology | Animals | Piperidines - pharmacology | Mice | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Morpholines - therapeutic use | Pyrazoles - pharmacology | Obesity | Cannabinoids | Cell receptors | Care and treatment | Development and progression | Properties | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Biochemical pharmacology, ISSN 0006-2952, 03/2017, Volume 128, pp. 1 - 11
Effector pathways | GPCR | Drug discovery | Biased agonism | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Receptors, Cannabinoid - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Signal Transduction | Drug Inverse Agonism | Humans | Cannabinoid Receptor Agonists - chemistry | Cannabinoid Receptor Agonists - pharmacology | Molecular Targeted Therapy | Drug Discovery | Tyrosine | Peptides | Sphingosine | Cyclic adenylic acid | Cellular signal transduction | G proteins | Adenylic acid | Mitogens | Protein kinases | Index Medicus | Effector Pathways
Journal Article
9.
Full Text
Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6
Scientific reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 890 - 890
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Carbamylation | Enzymes | Hydrolase | Therapeutic applications | Serine | Methionine | Ions | Mass spectroscopy | 2-Arachidonoylglycerol | Proteins | Trypsin | Affinity chromatography | Post-translation | Cannabinoid CB2 receptors | Catalysis | Protein structure | Index Medicus
Journal Article
Biological psychiatry (1969), ISSN 0006-3223, 2015, Volume 77, Issue 5, pp. 475 - 487
Psychiatry | Tolerance | CB2 | Precipitated withdrawal | Chemotherapy-induced neuropathic pain | Knockout mouse | Side effect | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Hyperalgesia - chemically induced | Tumor Necrosis Factor-alpha - metabolism | Spinal Cord - drug effects | Receptor, Cannabinoid, CB2 - agonists | Male | Cannabinoid Receptor Agonists - pharmacology | RNA, Messenger - metabolism | Receptor, Cannabinoid, CB2 - genetics | Paclitaxel - toxicity | Receptor, Cannabinoid, CB1 - agonists | Cannabinoid Receptor Antagonists - pharmacology | Female | Indoles - pharmacology | Chemokine CCL2 - metabolism | Chromones - pharmacology | Dronabinol - pharmacology | Disease Models, Animal | Mice, Inbred C57BL | Random Allocation | Hyperalgesia - physiopathology | Mice, Knockout | Antineoplastic Agents, Phytogenic - toxicity | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Receptor, Cannabinoid, CB1 - genetics | Hyperalgesia - drug therapy | Spinal Cord - physiopathology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Cannabinoids | Paclitaxel | Index Medicus
Journal Article